Intratumoral aromatase in human breast, endometrial, and ovarian malignancies

Endocrine Reviews

Volumn 19, Issue 5, 1998, Pages 593-607

  Sasano, Hironobu ^a   Harada, Nobuhiro ^b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; AROMATASE; AROMATASE INHIBITOR; ESTROGEN; TESTOSTERONE;

AROMATIZATION; BREAST CANCER; ENDOMETRIUM CANCER; ENZYME INHIBITION; ESTROGEN SYNTHESIS; GENETIC REGULATION; GYNECOMASTIA; HORMONAL CARCINOGENESIS; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE DEPENDENCE; HORMONE RECEPTOR INTERACTION; HUMAN; IMMUNOHISTOCHEMISTRY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SPLICEOSOME; TISSUE DISTRIBUTION;

AGED; ALTERNATIVE SPLICING; AROMATASE; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; ENDOMETRIAL NEOPLASMS; ESTRADIOL; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OVARIAN NEOPLASMS;

EID: 0031712804     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.19.5.593     Document Type: Review

References (154)

1. Henderson IC, Canellos GP 1990 Cancer of the breast: the past decade. N Engl J Med 302:17-30
2. Miller WR 1991 Aromatase activity in breast tissue. J Steroid Biochem Mol Biol 39:783-790
3. Schweikert HU, Milewich L, Wilson JD 1976 Aromatization of androstenedione by cultured human fibroblasts. J Clin Endocrinol Metab 43:785-795
4. Longcope C, Pratt JH, Schneider SH, Fineberg SE 1978 Aromatization of androgens by muscle and adipose tissue in vivo. J Clin Endocrinol Metab 46:146-152
5. Sasano H, Uzuki M, Sawai T, Nagura H, Matsunaga G, Kashimoto O, Harada N 1997 Aromatase in human bone tissue. J Bone Miner Res 12:1416-1423
6. Hobkirk R 1993 Steroid sulfation. Trends Endocrinol Metab 4:69-74
7. Reed MJ, Purohit A 1993 Sulphatase inhibitors. The rationale for the development of a new endocrine therapy. Rev Endocr Relat Cancer 45:51-62
8. Reed MJ, Purohit A, Howarth NM, Potter BVL 1994 Steroid sulphatase inhibitors: a new endocrine therapy. Drugs Future 19: 6734-6738
9. Peltoketo H, Isomaa V, Maentausta O, Vihko R 1988 Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett 239:73-77
10. Poutanen M, Isomaa V, Lehto VP, Vihko R 1992 Immunological analysis of 17β-hydroxysteroid dehydrogenase in benign and malignant human breast tissue. Int J Cancer 50:386-390
11. Poutanen M, Isomaa V, Peltoketo H, Vihko R 1995 Role of 17β-hydroxysteroid dehydrogenase type 1 in endocrine and intracrine estradiol biosynthesis. J Steroid Biochem Mol Biol 55:525-532
12. Sasano H, Sasano N 1989 What's new in the localization of sex steroids in the human ovary and its tumors? Pathol Res Pract 185:942-948
13. Sasano H, Okamoto M, Mason JI, Simpson ER, Mendelson CR, Sasano N, Silverberg SG 1989 Immunolocalization of aromatase, 17 alpha-hydroxylase and side-chain-cleavage cytochromes P-450 in the human ovary. J Reprod Fertil 85:163-169
14. Lipworth L, Adami HO, Trichopoulos D, Carlstrom K, Mantzoros C 1996 Serum steroid hormone levels, sex hormone-binding globulin, and body mass index in the etiology of postmenopausal breast cancer. Epidemiology 7:96-100
15. Dorgan JF, Stanczyk FZ, Longcope C, Stephenson Jr HE, Chang L, Miller R, Franz C, Falk RT, Kahle L 1997 Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 6:177-181
16. Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R, Pisani P, Panico S, Secreto G 1996 Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 88:291-296
17. James VHT, Reed MJ, Folkerd EJ 1981 Studies of oestrogen metabolism in postmenopausal women with cancer. J Steroid Biochem 15:235-245
18. Helzlsouer KJ, Gordon GB, Alberg AJ, Bush TL, Comstock GW 1992 Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer. Cancer Res 52:1-4
19. Cramer DW, Welch WR 1983 Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 71:717-721
20. MacDonald PC, Grodin JM, Edman CD, Vellios F, Siiteri PK 1976 Origin of estrogen in a postmenopausal woman with a nonendocrine tumor of the ovary and endometrial hyperplasia. Obstet Gynecol 47:644-650
21. Jeppsson S, Karlsson S, Kullander S 1986 Gondal steroids, gonadotropins and endometrial histology in postmenopausal women with malignant ovarian tumors. Acta Obstet Gynecol Scand 65: 207-210
22. Judd HL, Davidson BJ, Frumar AM, Shamonki IM, Lagasse LD, Ballon SC 1980 Serum androgens and estrogens in postmenopausal women with and without endometrial cancer. Am J Obstet Gynecol 136:859-871
23. Miller WR, Hawkins RA, Forrest AP 1982 Significance of aromatase activity in human breast cancer. Cancer Res 42[Suppl]: 3365s-3368s
24. Perel E, Wilkins D, Killinger DW 1980 The conversion of androstenedione to estrone, estradiol, and testosterone in breast tissue. J Steroid Biochem 13:89-94
25. Reed MJ, Owen AJ, Lai LC, Coldham NG, Ghilchik MW, Shaikh NA, James VHT 1989 In situ oestrogen synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione. Int J Cancer 44:233-237
26. Bradlow HL 1982 A reassessment of the role of breast tumor aromatase. Cancer Res 42[Suppl]:3382s-3386s
27. Thorsen T, Tangen M, Stoa KF 1982 Concentration of endogenous oestradiol as related to oestradiol receptor sites in breast tumor cytosol. Eur J Cancer Clin Oncol 18:333-337
28. van Landeghem AAJ, Portman J, Mabauurs M 1985 Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res 45:2900-2906
29. Yue W, Wang JP, Hamilton CJ, Demers LM, Santen RJ 1998 In situ aromatization enhances breast tumor estradiol levels and cellular proliferation. Cancer Res 58:927-932
30. de Jong PC, van de Ven J, Nortier HW, Maitimu-Smeele I, Donker TH, Thijssen JH, Slee PH, Blankenstein RA 1997 Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole. Cancer Res 57:2109-2111
31. Bezwoda WR, Mansoor N, Dansey R 1987 Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimide. Oncology 44:345-349
32. Tseng L, Mazella J, Mann WJ, Chumas J 1982 Estrogen synthesis in normal and malignant human endometrium. J Clin Endocrinol Metab 55:1029-1031
33. Yamaki J, Yamamoto T, Okada H 1985 Aromatization of androstenedione by normal and neoplasmic endometrium of the uterus. J Steroid Biochem 22:63-66
34. MacLusky NJ, Voit R, Lazo JS, Schwartz PE, Merino MJ, Eisenfeld AE, Naftolin F 1987 Aromatase activity in human ovarian cancer. Steroids 50:423-433
35. Slotman BJ, Kuhnel R, Rao BR, Dijkhuizen GH, de Graaff J, Stolk JG 1989 Importance of steroid receptor and aromatase activity in the prognosis of ovarian cancer: high tumor progesterone receptor levels correlate with longer survival. Gynecol Oncol 33:76-81
36. Noguchi T, Kitawaki J, Tamura T, Kim T, Kanno H, Yamamoto T, Okada H 1993 Relationship between aromatase activity and steroid receptor levels in ovarian tumors from postmenopausal women. J Steroid Biochem Mol Biol 44:657-660
37. Pasqualini JR, Chetrite G, Blacker C, Feinstein MC, Delalonde L, Talbi M, Maloche C 1996 Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J Clin Endocrinol Metab 81:1460-1464
38. Bolufer P, Ricart E, Lluch A, Vazquez C, Rodriguez A, Ruiz A, Llopis F, Garcia-Conde J, Romero R 1992 Aromatase activity and estradiol in human breast cancer: its relationship to estradiol and epidermal growth factor receptor and to tumor-node-metastasis staging. J Clin Oncol 10:438-446
39. Lipton A, Santen RJ, Santner SJ, Harvey HA, Sanders SI, Matthews YL 1992 Prognostic value of breast cancer aromatase. Cancer 70:1951-1955
40. Labrie F 1991 Intracrinology. Mol Cell Endocrinol 78:013-018
41. Labrie F, Belanger A, Simard J, Luu-The V, Labrie C 1995 DHEA and peripheral androgen and estrogen formation: intracrinology. Ann NY Acad Sci 774:16-28
42. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, Ito Y, Fisher CR, Michael MD, Mendelson CR, Bulun SE 1994 Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 15:342-355
43. Bulun SE, Simpson ER, Word RA 1994 Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture. J Clin Endocrinol Metab 78:736-743
44. Harada N, Yamada K, Saito K, Kibe N, Dohmae S, Takagi Y 1990 Structural characterization of the human estrogen synthetase (aromatase) gene. Biochem Biophys Res Commun 166:365-372
45. Means GD, Mahendroo MS, Corbin CJ, Mathis JM, Powell FE, Mendelson CR, Simpson ER 1989 Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J Biol Chem 264:19385-19391
46. Harada N, Utsumi T, Takagi Y 1993 Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proc Natl Acad Sci USA 90:11312-11316
47. Means GD, Kilgore MW, Mahendroo MS, Mendelson CR, Simpson ER 1991 Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. Mol Endocrinol 5:2005-2013
48. Mahendroo MS, Means GD, Mendelson CR, Simpson ER 1991 Tissue-specific expression of human P-450AROM: the promoter responsible for expression in adipose is different from that utilized in placenta. J Biol Chem 266:11276-11281
49. Honda S, Harada N, Takagi Y 1994 Novel exon 1 of the aromatase gene specific for aromatase transcripts in human brain. Biochem Biophys Res Commun 198:1153-1160
50. Harada N 1992 A unique aromatase (P450AROM) mRNA formed by alternative use of tissue-specific exons 1 in human skin fibroblasts. Biochem Biophys Res Commun 189:1001-1007
51. Zhou C, Zhou D, Esteban J, Murai J, Siiteri PK, Wilczynski S, Chen S 1996 Aromatase gene expression and its exon 1 usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction. J Steroid Biochem Mol Biol 59:163-171
52. Harada N, Yamada K 1992 Ontogeny of aromatase messenger ribonucleic acid in mouse brain. Fluorometrical quantitation by polymerase chain reaction. Endocrinology 131:2306-2312
53. Harada N, Yamada K, Foidart A, Balthazart J 1992 Regulation of aromatase cytochrome P-450 (estrogen synthetase) transcripts in the quail brain by testosterone. Brain Res Mol Brain Res 15:19-26
54. Sasano H, Takahashi K, Satoh F, Nagura H, Harada N 1998 Aromatase in human central nervous system. Clin Endocrinol (Oxf) 48:325-329
55. Miller WR, Anderson TJ, Jack WJ 1990 Relationship between tumor aromatase activity, tumor characteristics and response to therapy. J Steroid Biochem Mol Biol 37:1055-1059
56. Silva MC, Rowlands MG, Dowsett M, Gusterson B, McKinna JA, Fryatt I, Coombes RC 1989 Intratumoral aromatase as a prognostic factor in human breast carcinoma. Cancer Res 49:2588-2591
57. O'Neill JS, Elton RA, Miller WR 1988 Aromatase activity in adipose tissue from breast quadrants: a link with tumor site. Br Med J 296:741-743
58. Bulun SE, Price TM, Aitken J, Mahendroo MS, Simpson ER 1993 A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metab 77:1622-1628
59. Bulun SE, Simpson ER 1994 Regulation of aromatase expression in human tissues. Breast Cancer Res Treat 30:19-29
60. Utsumi T, Harada N, Maruta M, Takagi Y 1996 Presence of alternatively spliced transcripts of aromatase gene in human breast cancer. J Clin Endocrinol Metab 81:2344-2349
61. Bulun SE, Price TM, Aitken J, Mahendroo MS, Simpson ER 1993 A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts by competitive PCR. J Clin Endocrinol Metab 77:1622-1628
62. Sasano H 1994 Functional pathology of human ovarian steroidogenesis: normal cycling ovary and steroid-producing neoplasms. Endocr Pathol 5:81-89
63. Suzuki T, Sasano H, Sasaki H, Fukaya T, Nagura H 1994 Quantitation of P450 aromatase immunoreactivity in human ovary during the menstrual cycle: relationship between the enzyme activity and immunointensity. J Histochem Cytochem 42:1565-1573
64. Nakazumi H, Sasano H, Maehara I, Ozaki M, Tezuka F, Orikasa S 1996 Estrogen metabolism and impaired spermatogenesis in germ cell tumors of the testis. J Clin Endocrinol Metab 81:1289-1295
65. Sasano H, Okamoto M, Mason JI, Simpson ER, Mendelson CR, Sasano N, Silverberg SG 1989 Immunohistochemical studies of steroidogenic enzymes (aromatase, 17 alpha-hydroxylase and cholesterol side-chain cleavage cytochromes P-450) in sex cord-stromal tumors of the ovary. Hum Pathol 20:452-457
66. Sasano H, Nakashima N, Matsuzaki O, Kato H, Aizawa S, Sasano N, Nagura H 1992 Testicular sex cord-stromal lesions: immunohistochemical analysis of cytokeratin, vimentin and steroidogenic enzymes. Virchows Arch A Pathol Anat Histopathol 421:163-169
67. Sasano H, Nagura H, Harada N, Goukon Y, Kimura M 1994 Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol 25:530-535
68. Sasano H, Kimura M, Shizawa S, Kimura N, Nagura H 1996 Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study. J Clin Endocrinol Metabol 81:3063-3067
69. Sasano H, Frost AR, Saitoh R, Harada N, Poutanen M, Vihko R, Bulun SE, Silverberg SG, Nagura H 1996 Aromatase and 17 beta-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. J Clin Endocrinol Metab 81:4042-4046
70. Sasano H, Ozaki M 1997 Aromatase expression and its localization in human breast cancer. J Steroid Biochem Mol Biol 61:293-298
71. Santner SJ, Pauley RJ, Tait L, Kaseta J, Santen RJ 1997 Aromatase activity and expression in breast cancer and benign breast tissue stromal cells. J Clin Endocrinol Metab 82:200-208
72. Lu Q, Nakamura J, Savinov A, Yue W, Weisz J, Dabbs DJ, Wolz G, Brodie A 1996 Expression of aromatase protein and messenger ribonuccleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology 137:3061-3068
73. Santen RJ, Martel J, Hoagland M, Naftolin F, Roa L, Harada N, Hafer L, Zaino R, Santner SJ 1994 Stromal spindle cells contain aromatase in human breast tumors. J Clin Endocrinol Metab 79: 627-632
74. Esteban JM, Warsi Z, Haniu M, Hall P, Shively JE, Chen S 1992 Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation. Am J Pathol 140:337-343
75. Bulun SE, Sharda G, Rink J, Sharma S, Simpson ER 1996 Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast. J Clin Endocrinol Metab 81:1273-1277
76. Sasano H 1994 Application of mRNA in situ hybridization to surgical pathology materials. Acta Histochem Cytochem 27:567-571
77. Agarwal VR, Bulun SE, Leitch M, Rohrich R, Simpson ER 1996 Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J Clin Endocrinol Metab 81:3843-3849
78. Agarwal VR, Ashanullah CI, Simpson ER, Bulun SE 1997 Alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in adipose tissue of women. J Clin Endocrinol Metab 82:70-74
79. Zhou C, Zhou D, Esteban J, Murai J, Siiteri PK, Wilczynski S, Chen S 1996 Aromatase gene expression and its exon 1 usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction. J Steroid Biochem Mol Biol 59:163-171
80. Harada N, Utsumi T, Takagi Y 1995 Molecular and epidemiological analyses of abnormal expression of aromatase in breast cancer. Pharmacogenetics 5:559-564
81. Zhao Y, Agarwal VR, Mendelson CR, Simpson ER 1996 Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 137:5739-5742
82. Reed MJ, Purohit A 1997 Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis. Endocr Rev 18:701-715
83. Sourdaine P, Mullen P, White R, Telford J, Parker MG, Miller WR 1996 Aromatase activity and CYP19 gene expression in breast cancers. J Steroid Biochem Mol Biol 59:191-198
84. Mosselman S, Polman J, Dijkema R 1996 ER-β: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49-53
85. Brandenberger AW, Tee MK, Lee JY, Chao V, Jaffe RB 1997 Tissue distribution of estrogen receptors alpha (ER-α) and beta (ER-β) mRNA in the midgestational human fetus. J Clin Endocrinol Metab 82:3509-3512
86. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA 1996 Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:2925-2930
87. Dowsett M 1997 Aromatase inhibitors come of age. Ann Oncol 8:631-632
88. Dowsett M 1996 Endocrine treatment of advanced breast cancer. Acta Oncol 35[Suppl]5:68-72
89. Mabuchi K, Bross DS, Kessler II 1985 Risk factors for male breast cancer. J Natl Cancer Inst 74:371-375
90. American Cancer Society 1984 Cancer Facts and Figures, 1983. American Cancer Society, New York
91. Moolgavkar SH, Lee JA, Hade RD 1978 Comparison of age-specific mortality from breast cancer in males in the United States and Japan. J Natl Cancer Inst 60:1223-1225
92. Fox SB, Rogers S, Day CA, Underwood JC 1992 Oestrogen receptor and epidermal growth factor receptor expression in male breast carcinoma. J Pathol 166:13-18
93. Rogers S, Day CA, Fox SB 1993 Expression of cathepsin D and estrogen receptor in male breast carcinoma. Hum Pathol 24:148-151
94. Pich A, Margaria E, Chiusa L 1994 Proliferative activity is a significant prognostic factor in male breast carcinoma. Am J Pathol 145:481-489
95. Thomas DB 1993 Breast cancer in men. Epidemiol Rev 15:220-231
96. Silverberg SG, Kurman RJ 1996 Tumors of the Uterine Corpus and Gestational Trophoblastic Disease. Armed Forces Institute of Pathology, Washington DC
97. Haenszel W, Kurihara M 1968 Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40:43-68
98. Sasano H 1994 Emerging new technologies for evaluating endometrial hyperplasia and carcinoma. Adv Pathol Lab Med 7:517-531
99. Bokhman JV 1983 Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10-17
100. Smith M, McCartney J 1985 Occult, high-risk endometrial cancer. Gynecol Oncol 22:154-161
101. Sasano H, Watanabe K, Ito K, Sato S, Yajima A 1994 New concepts in the diagnosis and prognosis of endometrial carcinoma. Pathol Annu 29:31-49
102. Beckner ME, Mori T, Silverberg SG 1985 Endometrial carcinoma: nontumor factors in prognosis. Int J Gynecol Pathol 4:131-145
103. Sasano H, Comerford J, Wilkinson DS, Schwartz A, Garrett CT 1990 Serous papillary adenocarcinoma of the endometrium. Analysis of proto-oncogene amplification, flow cytometry, estrogen and progesterone receptors, and immunohistochemistry. Cancer 65: 1545-1551
104. Schenker JG, Weinstein D, Okon E 1979 Estradiol and testosterone levels in the peripheral and ovarian circulations in patients with endometrial cancer. Cancer 44:1809-1812
105. Nagasako S, Asanuma N, Nagata Y 1988 Plasma concentration of estrogens and androgens in postmenopausal women with or without endometrial cancer. Nippon Sanka Fujinka Gakkai Zasshi 40: 707-713
106. Yamamoto T, Kitawaki J, Urabe M, Honjo H, Tamura T, Noguchi T, Okada H, Sasaki H, Tada A, Terashima Y, Nakamura J, Yoshihama M 1993 Estrogen productivity of endometrium and endometrial cancer tissue; influence of aromatase on proliferation of endometrial cancer cells. J Steroid Biochem Mol Biol 44:463-468
107. Bulun SE, Economos K, Miller D, Simpson ER 1994 CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors. J Clin Endocrinol Metab 79:1831-1834
108. Sasano H, Kaga K, Sato S, Yajima A, Nagura H, Harada N 1996 Aromatase cytochrome P450 gene expression in endometrial carcinoma. Br J Cancer 74:1541-1544
109. Noble LS, Simpson ER, Johns A, Bulun SE 1996 Aromatase expression in endometriosis. J Clin Endocrinol Metab 81:174-179
110. Bulun SE, Mahendroo MS, Simpson ER 1993 Polymerase chain reaction amplification fails to detect aromatase cytochrome P450 transcripts in normal human endometrium or decidua. J Clin Endocrinol Metab 76:1458-1463
111. Kitawaki J, Noguchi T, Amatsu T, Maeda K, Tsukamoto K, Yamamoto T, Fushiki S, Osawa Y, Honjo H 1997 Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod 57:514-519
112. Noble LS, Takayama K, Zeitoun KM, Putman JM, Johns DA, Hinshelwood MM, Agarwal VR, Zhao Y, Carr BR, Bulun SE 1997 Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab 82:600-606
113. Yamamoto T, Noguchi T, Tamura T, Kitawaki J, Okada H 1993 Evidence for estrogen synthesis in adenomyotic tissues. Am J Obstet Gynecol 169:734-738
114. Watanabe K, Sasano H, Harada N, Ozaki M, Niikura H, Sato S, Yajima A 1995 Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies. Am J Pathol 146:491-500
115. Reed MJ, Coldham NG, Patel SR, Ghilchik MW, James VH 1992 Interluekin-1 and interleukin-6 in breast cyst fluid: their role in regulating aromatase activity in breast cancer cells. J Endocrinol 132:R5-R8
116. Wilking N, Isaksson E, von Schoultz E 1997 Tamoxifen and secondary tumours. An update [Review]. Drug Safety 16:104-117
117. Mäentausta O, Sormunen R, Isomaa V, Lehto VP, Jouppila P, Vihko R 1991 immunohistochemical localization of 17β-hydroxysteroid dehydrogenase in the human endometrium during the menstrual cycle. Lab Invest 65:582-587
118. Mäentausta O, Boman K, Isomaa V, Stendahl U, Bäckström T, Vihko R 1992 Immunohistochemical study of the human 17β-hydroxysteroid dehydrogenase and steroid receptors in endometrial adenocarcinoma. Cancer 70:1551-1555
119. Jenkins C, Michael D, Mahendroo M, Simpson E 1993 Exon-specific Northern analysis and rapid amplification of cDNA ends (RACE) reveal that the proximal promoter II (PII) is responsible for aromatase cytochrome P450 (CYP19) expression in human ovary. Mol Cell Endocrinol 97:R1-R6
120. Suzuki T, Sasano H, Tamura M, Aoki H, Fukaya T, Yajima A, Nagura H, Mason JI 1993 Temporal and spatial localization of steroidogenic enzymes in premenopausal human ovaries: in situ hybridization and immunohistochemical study. Mol Cell Endocrinol 97:135-143
121. Suzuki T, Sasano H, Kimura N, Tamura M, Fukaya T, Yajima A, Nagura H 1994 Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: relationship to expression of steroidogenic enzymes. Hum Reprod 9:1589-1595
122. Inkster SE, Brodie AM 1991 Expression of aromatase cytochrome P450 in premenopausal and postmenopausal human ovaries: an immunocytochemical study. J Clin Endocrinol Metab 73:717-726
123. Jones GS 1990 Corpus luteum: composition and function. Fertil Steril 54:21-26
124. Matsuda H, Fujita H, Ishikura E, Osawa Y 1984 Immunocytochemical localization of aromatase in ovaries of some rodents, cow and human. Acta Histochem Cytochem 17:311-322
125. Sasano H, Suzuki T, Niikura H, Kaga K, Sato S, Yajima A, Rainey WE, Nagura H 1996 17β-Hydroxysteroid dehydrogenase in common epithelial ovarian tumors. Mod Pathol 9:386-391
126. Young RH, Scully RE 1987 Sex cord-stromal, steroid cell and other ovarian tumors with endocrine, paraendocrine, and paraneoplastic manifestations. In: Kurman RJ (ed) Blaustein's Pathology of the Female Genital Tract. Springer-Verlag, New York, pp 607-658
127. Hilliard GD, Norris HJ 1982 The ovaries in endocrine disorders. In Bloodworth JMB (ed) Endocrine Pathology. Williams & Wilkins, Baltimore, pp 267-290
128. Sasano H, Mason JI, Sasaki E, Yajima A, Kimura N, Namiki T, Sasano N, Nagura H 1990 Immunohistochemical study of 3 beta-hydroxysteroid dehydrogenase in sex cord-stromal tumors of the ovary. Int J Gynecol Pathol 9:352-362
129. Costa MJ, Morris R, Sasano H 1994 Sex steroid biosynthesis enzymes in ovarian sex-cord stromal tumors. Int J Gynecol Pathol 13:109-119
130. Takayama K, Sasano H, Fukaya T, Morohashi K, Suzuki T, Tamura M, Costa MJ, Yajima A 1995 Immunohistochemical localization of Ad4-binding protein with correlation to steroidogenic enzyme expression in cycling human ovaries and sex cord stromal tumors. J Clin Endocrinol Metab 80:2815-2821
131. Bulun SE, Rosenthal IM, Brodie AM, Inkster SE, Zeller WP, DiGeorge AM, Frasier SD, Kilgore MW, Simpson ER 1994 Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads [corrected and republished with original paging; article originally printed in J Clin Endocrinol Metab 1993 77:1616-1621] J Clin Endocrinol Metab 78:1616-1621
132. Schwartz PE 1987 Sex cord-stromal tumors of the ovary. In: Piver MS (ed) Ovarian Malignancies: Diagnostics and Therapeutic Advances. Churchhill Livingstone, New York, pp 251-271
133. Koonings PP, Campbell K, Mishell Jr DR, Grimes DA 1989 Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol 74:921-926
134. Katsube Y, Berg JW, Silverberg SG 1982 Epidemiologic pathology of ovarian tumors: a histopathologic review of primary ovarian neoplasms diagnosed in the Denver Standard Metropolitan Statistical Area, 1 July-31 December 1969 and 1 July-31 December 1979. Int J Gynecol Pathol 1:3-16
135. Rao BR, Slotman BJ 1991 Endocrine factors in common epithelial ovarian cancer. Endocr Rev 12:13-26
136. Stadel BV 1975 The etiology and prevention of ovarian cancer (letter). Am J Obstet Gynecol 123:772-774
137. Langley FA, Fox H 1995 Ovarian tumours: classification, histogenesis and aetiology. In: Fox H (ed) Haines and Taylor: Obstetrical and Gynecological Pathology, ed 4. Churchill Livingstone, New York, pp 727-742
138. Kaga K, Sasano H, Harada N, Ozaki M, Sato S, Yajima A 1996 Aromatase in human common epithelial ovarian neoplasms. Am J Pathol 149:45-51
139. Imai A, Ohno T, Takahashi K, Furui T, Tamaya T 1994 Lack of evidence for aromatase expression in human ovarian epithelial carcinoma. Ann Clin Biochem 31:65-71
140. Sasano H, Kaga K, Sato S, Yajima A, Nagura H 1996 Adrenal 4-binding protein in common epithelial and metastatic tumors of the ovary. Hum Pathol 27:595-598
141. Kitawaki J, Noguchi T, Yamamoto T, Yokota K, Maeda K, Urabe M, Honjo H 1996 Immunohistochemical localization of aromatase and its correlation with progesterone receptors in ovarian epithelial tumors. Anticancer Res 16:91-97
142. Doody KJ, Lorence MC, Mason JI, Simpson ER 1990 Expression of messenger ribonucleic acid species encoding steroidogenic enzymes in human follicles and corpora lutea throughout the menstrual cycle. J Clin Endocrinol Metab 70:1041-1045
143. Kitawaki J, Inoue S, Tamura T, Yamamoto T, Noguchi T, Osawa Y, Okada H 1992 Increasing aromatase cytochrome P-450 level in human placenta during pregnancy: studied by immunohistochemistry and enzyme-linked immunosorbent assay. Endocrinology 130:2751-2757
144. Thompson Jr EA, Siiteri PK 1974 Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J Biol Chem 249:5364-5372
145. Noguchi T, Kitawaki J, Tamura T, Kanno H, Kim T, Maeda K, Yamamoto T, Okada H 1993 Relationship among aromatase activity, estrogen receptor and progesterone receptor in ovarian tumors from postmenopausal women. Nippon Sanka Fujinka Gakkai Zasshi 45:1123-1128
146. Scully RE, Cohen RE 1964 Oxidative-enzyme activity in normal and pathologic human ovaries. Obstet Gynecol 24:667-681
147. Czernobilsky B 1987 Common epithelial tumors of the ovary. In: Kurman RJ (ed) Blaustein's Pathology of the Female Genital Tract. Springer-Verlag, New York, pp 560-606
148. Melmed S, Braunstein GD, Hershman JM, Wade ME 1983 Modulation of ectopic secretion of human chorionic gonadotropin by cultured ovarian adenocarcinoma cells. Gynecol Oncol 16:49-55
149. Deleted in proof
150. Sasano H, Fukunaga M, Rojas M, Silverberg SG 1989 Hyperthecosis of the ovary. Clinicopathologic study of 19 cases with immunohistochemical analysis of steroidogenic enzymes. Int J Gynecol Pathol 8:311-320
151. Takayama K, Fukaya T, Sasano H, Funayama Y, Suzuki T, Takaya R, Wada Y, Yajima A 1996 Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome. Hum Reprod 11:1387-1392
152. Toki T, Fujii S, Silverberg SG 1996 A clinicopathologic study on association of endometriosis and carcinoma of the ovary using a scoring system. Int J Gynecol Cancer 6:68-75
153. Scully RE 1987 Ovarian tumours with functioning stroma. In: Fox H (ed) Haines and Taylor Obstetrical and Gynecological Pathology, ed 3. Churchill Livingstone, New York, vol 2:724-436
154. Rutgers JL, Scully RE 1986 Functioning ovarian tumors with peripheral steroid cell proliferation. A report of twenty-four cases. Int J Gynecol Pathol 5:319-337